Global Exome Sequencing Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2028

The global exome sequencing market is anticipated to grow at a significant CAGR of 20.1% during the forecast period (2022-2028). Exome sequencing is a method for sequencing a genome’s whole-exome and protein-coding genes. This method comprises first identifying the DNA segments that code for proteins or exons, and then sequencing the exonic DNA using high-throughput DNA sequencing technology. It is now commonly used to find and determine genetic abnormalities that cause illnesses, including Miller syndrome and Alzheimer’s disease.

The rising applications of exome sequencing in clinical diagnostics, high demand for the diagnosis of rare diseases, expanding R&D in the field of genomics and next-generation sequencing, and increasing need for customized medicine are the primary factors driving the global exome sequencing market. Additionally, the market is being driven by the rising adoption of next-generation sequencing approaches for the prediction, treatment, and monitoring of a variety of chronic diseases, such as cancer. Moreover, other secondary driving factors of the market include the economical cost and high speed associated with exome sequencing technology, technological improvements in whole-exome sequencing techniques, and global partnerships among prominent research institutes.

The North American region holds the largest share in the market. The key reasons driving the growth of the exome sequencing market in this region include the rising prevalence of hereditary and chronic illnesses, such as cancer, the rising need for targeted and customized therapy, and supportive government initiatives. The Asia-Pacific region is expected to grow with the highest CAGR during the forecast period. The key driving reasons for the Asia-Pacific exome sequencing market are regular government funding and a significant number of conferences linked to the exome sequencing technique.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, in order to stay competitive in the market. For instance-

• In June 2019, BGI Genomics has released an exome sequencing solution for clinical research, that is paired with Congenica’s clinical interpretation services. BGI Genomics’ service laboratories will do the sequencing, while qualified clinical scientists will interpret the results using the CongenicaTM clinical decision support platform, which is trusted by Genomics England and the NHS Genomic Medicine Service.
• In April 2019, Natera, Inc., one of the market players in cell-free DNA testing, has revealed plans to market a research-use-only (RUO) whole-exome sequencing (WES) of circulating tumor DNA utilizing plasma samples from cancer patients.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product
  • By Technology
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- Agilent Technologies Inc., Ambry Genetics Corp., Beijing Genomics Institute, Bio-Rad Laboratories Inc., and Eurofins Scientific Group, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Exome Sequencing Market Report by Segment

By Product

• Systems
• Kits
• Services

By Technology

• Sequencing by Synthesis
• ION Semiconductor Sequencing
• Others

By Application

• Diagnostics
• Drug Discovery and Development
• Personalized Medicine
• Agriculture & Animal Research
• Others

By End-User

• Hospitals & Clinics
• Academic & Government Institutes
• Pharmaceutical & Biotechnology Companies
• Others